Kura Oncology (KURA) Interest & Investment Income (2015 - 2026)
Kura Oncology (KURA) reported Interest & Investment Income of $5.8 million for Q1 2026, down 26.06% year-over-year from $7.9 million in Q1 2025, and down 26.06% on a QoQ basis from $7.9 million in Q1 2025.
Kura Oncology (KURA) has 12 years of Interest & Investment Income data on file, last reported at $5.8 million in Q1 2026.
- Quarterly Interest & Investment Income fell 26.06% year-over-year to $5.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (down 0.58% YoY) and the FY2025 annual result came in at $26.8 million, up 17.18% from the prior year.
- Interest & Investment Income slipped to $5.8 million in Q1 2026 per KURA's latest filing, from $7.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $7.9 million in Q1 2025 and bottomed at $329000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $4.3 million (2023), against an average of $4.0 million.
- The widest annual swing landed in 2023, when Interest & Investment Income surged 769.6%; it then fell 26.06% in 2026.
- Tracing KURA's Interest & Investment Income over 5 years: stood at $2.3 million in 2022, then soared by 92.43% to $4.4 million in 2023, then grew by 29.5% to $5.7 million in 2024, then soared by 39.23% to $7.9 million in 2025, then slipped by 26.06% to $5.8 million in 2026.
- Per Business Quant, the three latest KURA Interest & Investment Income figures stand at $5.8 million (Q1 2026), $7.9 million (Q1 2025), and $5.7 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Kura Oncology | 801.92 Mn | 801.92 Mn | 18.00 Mn | 5.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.83 Mn |
| Mar 31, 2025 | 7.88 Mn |
| Dec 31, 2024 | 5.66 Mn |
| Sep 30, 2024 | 5.89 Mn |
| Jun 30, 2024 | 5.97 Mn |
| Mar 31, 2024 | 5.33 Mn |
| Dec 31, 2023 | 4.37 Mn |
| Sep 30, 2023 | 4.28 Mn |
| Jun 30, 2023 | 3.22 Mn |
| Mar 31, 2023 | 2.86 Mn |
| Dec 31, 2022 | 2.27 Mn |
| Sep 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 564,000.00 |
| Mar 31, 2022 | 329,000.00 |
| Dec 31, 2021 | 295,000.00 |
| Sep 30, 2021 | 311,000.00 |
| Jun 30, 2021 | 290,000.00 |
| Mar 31, 2021 | 310,000.00 |
| Dec 31, 2020 | 317,000.00 |
| Sep 30, 2020 | 571,000.00 |
| Jun 30, 2020 | 830,000.00 |
| Mar 31, 2020 | 1.12 Mn |
| Dec 31, 2019 | 1.47 Mn |
| Sep 30, 2019 | 1.40 Mn |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 1.03 Mn |
| Dec 31, 2018 | 1.05 Mn |
| Sep 30, 2018 | 1.05 Mn |
| Jun 30, 2018 | 624,000.00 |
| Mar 31, 2018 | 450,000.00 |
| Dec 31, 2017 | 302,000.00 |
| Sep 30, 2017 | 197,000.00 |
| Jun 30, 2017 | 124,000.00 |
| Mar 31, 2017 | 128,000.00 |
| Dec 31, 2016 | 130,000.00 |
| Sep 30, 2016 | 131,000.00 |
| Jun 30, 2016 | 124,000.00 |
| Mar 31, 2016 | 114,000.00 |
| Dec 31, 2015 | 68,000.00 |
| Sep 30, 2015 | 38,000.00 |
| Jun 30, 2015 | 22,000.00 |